Your browser doesn't support javascript.
loading
Seasonal Betacoronavirus Antibodies' Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization.
Dispinseri, Stefania; Marzinotto, Ilaria; Brigatti, Cristina; Pirillo, Maria Franca; Tolazzi, Monica; Bazzigaluppi, Elena; Canitano, Andrea; Borghi, Martina; Gallinaro, Alessandra; Caccia, Roberta; Vercesi, Riccardo; McKay, Paul F; Ciceri, Fabio; Piemonti, Lorenzo; Negri, Donatella; Cinque, Paola; Cara, Andrea; Scarlatti, Gabriella; Lampasona, Vito.
Afiliação
  • Dispinseri S; Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele, 20132, Milan, Italy.
  • Marzinotto I; Diabetes Research Institute, IRCCS Ospedale San Raffaele, 20132, Milan, Italy.
  • Brigatti C; Diabetes Research Institute, IRCCS Ospedale San Raffaele, 20132, Milan, Italy.
  • Pirillo MF; National Center for Global Health, Istituto Superiore Di Sanità, 00161, Rome, Italy.
  • Tolazzi M; Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele, 20132, Milan, Italy.
  • Bazzigaluppi E; Diabetes Research Institute, IRCCS Ospedale San Raffaele, 20132, Milan, Italy.
  • Canitano A; National Center for Global Health, Istituto Superiore Di Sanità, 00161, Rome, Italy.
  • Borghi M; Department of Infectious Diseases, Istituto Superiore Di Sanità, 00161, Rome, Italy.
  • Gallinaro A; National Center for Global Health, Istituto Superiore Di Sanità, 00161, Rome, Italy.
  • Caccia R; Unit of Infectious Diseases, IRCCS Ospedale San Raffaele, 20132, Milan, Italy.
  • Vercesi R; Unit of Infectious Diseases, IRCCS Ospedale San Raffaele, 20132, Milan, Italy.
  • McKay PF; Department of Infectious Disease, Imperial College, London, UK.
  • Ciceri F; School of Medicine and Surgery, Università Vita-Salute San Raffaele, 20132, Milan, Italy.
  • Piemonti L; Hematology and Bone Marrow Transplantation Unit, IRCCS Ospedale San Raffaele, 20132, Milan, Italy.
  • Negri D; Diabetes Research Institute, IRCCS Ospedale San Raffaele, 20132, Milan, Italy.
  • Cinque P; School of Medicine and Surgery, Università Vita-Salute San Raffaele, 20132, Milan, Italy.
  • Cara A; Department of Infectious Diseases, Istituto Superiore Di Sanità, 00161, Rome, Italy.
  • Scarlatti G; Unit of Infectious Diseases, IRCCS Ospedale San Raffaele, 20132, Milan, Italy.
  • Lampasona V; National Center for Global Health, Istituto Superiore Di Sanità, 00161, Rome, Italy.
J Clin Immunol ; 42(3): 448-458, 2022 04.
Article em En | MEDLINE | ID: mdl-35000058
ABSTRACT
SARS-CoV-2 vaccination is known to induce antibodies that recognize also variants of concerns (VoCs) of the virus. However, epidemiological and laboratory evidences indicate that these antibodies have a reduced neutralization ability against VoCs. We studied binding and neutralizing antibodies against the Spike protein domains and subunits of the Wuhan-Hu-1 virus and its alpha, beta, delta VoCs and of seasonal betacoronaviruses (HKU1 and OC43) in a cohort of 31 health care workers prospectively followed post-vaccination with BNT162b2-Comirnaty. The study of sequential samples collected up to 64 days post-vaccination showed that serological assays measuring IgG against Wuhan-Hu-1 antigens were a poor proxy for VoC neutralization. In addition, in subjects who had asymptomatic or mild COVID-19 prior to vaccination, the loss of nAbs following disease could be rapid and accompanied by post-vaccination antibody levels similar to those of naïve vaccinees. Interestingly, in health care workers naïve for SARS-CoV-2 infection, vaccination induced a rapid and transient reactivation of pre-existing seasonal coronaviruses IgG responses that was associated with a subsequent reduced ability to neutralize alpha and beta VoCs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article